Signs of increased risk in some trials may stem from their high doses and high-CV-risk populations, propose researchers whose study saw no such concerns from normal dietary intake.
Serial NT-proBNP assays could potentially identify which of those without clinical disease might most benefit from heart-failure preventive therapies, researchers propose.
HeartCare study IDs patients genetic risk for cardiovascular disease miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.